TEXT OF STORYLISA NAPOLI: We spend a lot of time here on the morning shift at Marketplace talking about what we do to in order to get some sleep. A new report says drug companies sold more than $6 billion worth of sleep aids last year, and that figure is growing. From the Marketplace Innovations Desk at North Carolina Public Radio, Janet Babin reports.
JANET BABIN: The report from Datamonitor studied seven major markets, including the U.S., France, Germany and Japan. It predicts that sleep aids sales will reach nearly $8 billion by 2016.
Dr. Rafael Pelayo says the number could go even higher. He’s with the Stanford Sleep Disorders Clinic and also consults for drug companies.
RAFAEL PELAYO: Insomnia is not gonna go away because the population is aging. As people get older, they have more insomnia and there’s greater demand on our time. There’s more 24/7 society.
Pelayo says a lot of people don’t even see a doctor for insomnia because they don’t want to get addicted to a pill. And he says there are things people can do to enhance sleep without medication.
But a new class of sleep drugs holds great potential because they’re less addictive. Sanofi-Aventis, the current sleep drug leader, has two of these drugs that are close to hitting the market.
I’m Janet Babin for Marketplace.
We’re here to help you navigate this changed world and economy.
Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.
In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.
Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.